Cargando…

Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus

Human cytomegalovirus (HCMV) is an important, ubiquitous pathogen that causes severe clinical disease in immunocompromised individuals, such as organ transplant recipients and infants infected in utero. Antiviral chemotherapy remains problematic due to toxicity of the available compounds and the eme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bootz, Anna, Karbach, Astrid, Spindler, Johannes, Kropff, Barbara, Reuter, Nina, Sticht, Heinrich, Winkler, Thomas H., Britt, William J., Mach, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595347/ https://www.ncbi.nlm.nih.gov/pubmed/28854233 http://dx.doi.org/10.1371/journal.ppat.1006601

Ejemplares similares

Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
por: Kropff, Barbara, et al.
Publicado: (2012)

Structural Basis for the Recognition of Human Cytomegalovirus Glycoprotein B by a Neutralizing Human Antibody
por: Spindler, Nadja, et al.
Publicado: (2014)

Neutralizing Antibodies Limit Cell-Associated Spread of Human Cytomegalovirus in Epithelial Cells and Fibroblasts
por: Reuter, Nina, et al.
Publicado: (2022)

B Cell Repertoire Analysis Identifies New Antigenic Domains on Glycoprotein B of Human Cytomegalovirus which Are Target of Neutralizing Antibodies
por: Pötzsch, Sonja, et al.
Publicado: (2011)

Association of human cytomegalovirus (HCMV) neutralizing antibodies with antibodies to the HCMV glycoprotein complexes
por: Shibamura, Miho, et al.
Publicado: (2020)

Differences in Growth Properties among Two Human Cytomegalovirus Glycoprotein O Genotypes
por: Kalser, Julia, et al.
Publicado: (2017)

Polymorphic Forms of Human Cytomegalovirus Glycoprotein O Protect against Neutralization of Fibroblast Entry by Antibodies Targeting Epitopes Defined by Glycoproteins H and L
por: He, Li, et al.
Publicado: (2022)

Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection
por: Brouwer, Philip J.M., et al.
Publicado: (2022)

Human Cytomegalovirus Envelope Protein gpUL132 Regulates Infectious Virus Production through Formation of the Viral Assembly Compartment
por: Wu, Hui, et al.
Publicado: (2020)

Neutralization Epitopes in Trimer and Pentamer Complexes Recognized by Potent Cytomegalovirus-Neutralizing Human Monoclonal Antibodies
por: Ai, Yuanbao, et al.
Publicado: (2022)

IgA binds to the AD‐2 epitope of glycoprotein B and neutralizes human cytomegalovirus
por: Siddiqui, Saima, et al.
Publicado: (2020)

A fully human neutralizing monoclonal antibody targeting a highly conserved epitope of the human cytomegalovirus glycoprotein B
por: Okamoto, Miwa, et al.
Publicado: (2023)

Structural conservation of Lassa virus glycoproteins and recognition by neutralizing antibodies
por: Perrett, Hailee R., et al.
Publicado: (2023)

Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera
por: Luo, Yong, et al.
Publicado: (2016)

Epitope-Specific Humoral Responses to Human Cytomegalovirus Glycoprotein-B Vaccine With MF59: Anti-AD2 Levels Correlate With Protection From Viremia
por: Baraniak, Ilona, et al.
Publicado: (2018)

Neutralizing Antibody Responses Induced by HIV-1 Envelope Glycoprotein SOSIP Trimers Derived from Elite Neutralizers
por: Schorcht, Anna, et al.
Publicado: (2020)

SARS-CoV-2 Spike Protein Is Capable of Inducing Cell–Cell Fusions Independent from Its Receptor ACE2 and This Activity Can Be Impaired by Furin Inhibitors or a Subset of Monoclonal Antibodies
por: Reuter, Nina, et al.
Publicado: (2023)

Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies
por: Torrents de la Peña, Alba, et al.
Publicado: (2018)

Glycoprotein B Antibodies Completely Neutralize EBV Infection of B Cells
por: Hong, Junping, et al.
Publicado: (2022)

Maternal Fc-mediated non-neutralizing antibody responses correlate with protection against congenital human cytomegalovirus infection
por: Semmes, Eleanor C., et al.
Publicado: (2022)

Neutralizing Monoclonal Antibodies Reduce Human Cytomegalovirus Infection and Spread in Developing Placentas
por: Tabata, Takako, et al.
Publicado: (2019)

Development of broadly neutralizing antibodies targeting the cytomegalovirus subdominant antigen gH
por: Parsons, Andrea J., et al.
Publicado: (2022)

A non-neutralizing glycoprotein B monoclonal antibody protects against herpes simplex virus disease in mice
por: Kuraoka, Masayuki, et al.
Publicado: (2023)

Genetic Signatures in the Envelope Glycoproteins of HIV-1 that Associate with Broadly Neutralizing Antibodies
por: Gnanakaran, S., et al.
Publicado: (2010)

Measles Virus Glycoprotein-Based Lentiviral Targeting Vectors That Avoid Neutralizing Antibodies
por: Kneissl, Sabrina, et al.
Publicado: (2012)

Structural basis for broad neutralization of ebolaviruses by an antibody targeting the glycoprotein fusion loop
por: Janus, Benjamin M., et al.
Publicado: (2018)

Characterization of Single-Chain Fv Fragments of Neutralizing Antibodies to Rabies Virus Glycoprotein
por: Yumoto, Kohei, et al.
Publicado: (2021)

Two Akabane virus glycoprotein Gc domains induce neutralizing antibodies in mice
por: OGAWA, Yohsuke, et al.
Publicado: (2022)

In Silico Analysis of Neutralizing Antibody Epitopes on The Hepatitis C Virus Surface Glycoproteins
por: Zareh-Khoshchehreh, Raziyeh, et al.
Publicado: (2023)

Non-neutralizing antibodies and vaccine-induced protection
por: Demberg, Thorsten, et al.
Publicado: (2006)

Potent Bispecific Neutralizing Antibody Targeting Glycoprotein B and the gH/gL/pUL128/130/131 Complex of Human Cytomegalovirus
por: Su, Hang, et al.
Publicado: (2021)

Antibody-dependent cellular cytotoxicity, infected cell binding and neutralization by antibodies to the SIV envelope glycoprotein
por: Grunst, Michael W., et al.
Publicado: (2023)

Neutralization of Human Cytomegalovirus Entry into Fibroblasts and Epithelial Cells
por: Wussow, Felix, et al.
Publicado: (2017)

Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB/MF59 vaccination
por: Li, Fengsheng, et al.
Publicado: (2017)

Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein
por: Owsianka, Ania M., et al.
Publicado: (2008)

Structure of HCMV glycoprotein B in the postfusion conformation bound to a neutralizing human antibody
por: Chandramouli, Sumana, et al.
Publicado: (2015)

Antibody Binding to SARS-CoV-2 S Glycoprotein Correlates with but Does Not Predict Neutralization
por: Ding, Shilei, et al.
Publicado: (2020)

A novel glycoprotein D-specific monoclonal antibody neutralizes herpes simplex virus
por: Du, Ruikun, et al.
Publicado: (2017)

Structure of the rabies virus glycoprotein trimer bound to a prefusion-specific neutralizing antibody
por: Callaway, Heather M., et al.
Publicado: (2022)

Ricin Antibodies’ Neutralizing Capacity against Different Ricin Isoforms and Cultivars
por: Orsini Delgado, Maria Lucia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rma6itjntrba3hh2odffqcu24m